Literature DB >> 10088161

11C-acetate clearance in nasopharyngeal carcinoma.

S H Yeh1, R S Liu, L C Wu, S H Yen, C W Chang, K Y Chen.   

Abstract

This study assessed 11C-acetate turnover (clearance) in nasopharyngeal carcinoma (NPC). Data were acquired by dynamic PET after the intravenous injection of 4.625 MBq.kg-1 body weight of 11C-acetate for 30 min. Tomograms were reconstructed and evaluated visually. A time-activity curve of the nasopharynx and neck was generated and the clearance rate of 11C-acetate from the nasopharynx in the slow phase and from NPC was calculated using 0.693/T1/2. Ten patients with nasopharyngeal carcinoma and nine normal subjects were studied. The clearance of 11C-acetate from the normal nasopharynx was rapid and biexponential, in contrast to the rapid uptake followed by extremely slow clearance in patients with NPC. The clearance rate (mean +/- S.D.) was 0.0074 +/- 0.0042 in NPC and 0.0263 +/- 0.0152 in controls in the slow phase, being significantly different between the two groups with no overlap. All nasopharyngeal carcinomas were clearly visualized, in contrast to no obvious retention in the normal nasopharynx. Our initial results indicate that 11C-acetate clearance can be used to differentiate nasopharyngeal carcinoma from a normal nasopharynx. This finding may lead to new applications of 11C-acetate in oncology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088161     DOI: 10.1097/00006231-199902000-00004

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  1-[11C]-acetate PET imaging in head and neck cancer--a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning.

Authors:  Aijun Sun; Jens Sörensen; Mikael Karlsson; Ingela Turesson; Bengt Langström; Per Nilsson; Lena Cederblad; Jan Bertling; Katrine Riklund; Silvia Johansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-05       Impact factor: 9.236

2.  [1-(11)C]acetate uptake is not increased in renal cell carcinoma.

Authors:  J Kotzerke; C Linné; M Meinhardt; J Steinbach; M Wirth; G Baretton; N Abolmaali; B Beuthien-Baumann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-30       Impact factor: 9.236

3.  PET imaging of brain astrocytoma with 1-11C-acetate.

Authors:  Ren-Shyan Liu; Cheng-Pei Chang; Lee-Shing Chu; Yum-Kung Chu; Hung-Jen Hsieh; Chi-Wei Chang; Bang-Hung Yang; Shan-Hui Yen; Min-Chao Huang; Su-Quin Liao; Shin-Hwa Yeh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-11       Impact factor: 9.236

4.  11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.

Authors:  Kotaro Higashi; Yoshimichi Ueda; Ichiro Matsunari; Yuko Kodama; Ryosuke Ikeda; Katsuyuki Miura; Suzuka Taki; Takahiro Higuchi; Hisao Tonami; Itaru Yamamoto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

5.  SPECT and PET imaging of meningiomas.

Authors:  Varvara Valotassiou; Anastasia Leondi; George Angelidis; Dimitrios Psimadas; Panagiotis Georgoulias
Journal:  ScientificWorldJournal       Date:  2012-05-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.